Citizens Jmp Issues Pessimistic Forecast for NSRX (NYSEAMERICAN:NSRX) Stock Price

NSRX (NYSEAMERICAN:NSRX) had its price target lowered by stock analysts at Citizens Jmp from $19.00 to $18.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “market outperform” rating on the stock.

NSRX Stock Down 7.9%

NYSEAMERICAN:NSRX opened at $2.21 on Thursday. The business’s fifty day moving average is $4.91. NSRX has a fifty-two week low of $2.14 and a fifty-two week high of $9.99.

NSRX Company Profile

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.